Collaborations and Partnerships

Medicenna strongly supports scientific collaboration and we welcome interest from potential collaborators, in both industry and academia. If you would like to learn more about potential collaborative opportunities, please contact us

Cancer Prevention and Research Institute of Texas (CPRIT)

Medicenna’s MDNA55 program has been supported by US$14.1M in non dilutive funding awarded by CPRIT to Medicenna. This funding was used to support the now completed Phase 2 clinical trial of MDNA55 for the treatment of recurrent glioblastoma.